日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

XA-Novo: high-throughput mass spectrometry-based de novo sequencing technology for monoclonal antibodies and antibody mixtures

XA-Novo:基于高通量质谱的单克隆抗体和抗体混合物从头测序技术

Xiong, Yueting; Jiang, Wenbin; Xiao, Jin; Bu, Qingfang; Wang, Jingyi; Jiang, Zhenjian; Luo, Ling; Chen, Xiaoqing; Qiu, Yijie; Wu, Yangtao; Liu, Fan; Yu, Rongshan; Xia, Ningshao; Yuan, Quan

Multidimensional Proteomic Landscape Reveals Distinct Activated Pathways Between Human Brain Tumors

多维蛋白质组学图谱揭示人类脑肿瘤间不同的激活通路

Yang, Shuang; Zheng, Yongtao; Zhou, Chengbin; Yao, Jun; Yan, Guoquan; Shen, Chengpin; Kong, Siyuan; Xiong, Yueting; Sun, Qingfang; Sun, Yuhao; Shen, Huali; Bian, Liuguan; Qian, Kun; Liu, Xiaohui

CKAP4 and PLOD2 as novel prognostic biomarkers in hepatocellular carcinoma: a proteomics-driven risk stratification model.

CKAP4 和 PLOD2 作为肝细胞癌的新型预后生物标志物:蛋白质组学驱动的风险分层模型

Lu Qiulong, Cao Zhao, Xiong Yueting, Huang Junqiang, Zeng Huan, Chen Zhijian, Shu You, Tan Yahan, Long Xiaoling, Liu Xiaohui, Shu Hong

A Comprehensive Proteome Analysis of Peripheral Blood Mononuclear Cells (PBMCs) to Identify Candidate Biomarkers of Pancreatic Cancer

对外周血单核细胞 (PBMC) 进行全面的蛋白质组分析,以鉴定胰腺癌的候选生物标志物

Li, Hengchao; Mao, Yishen; Xiong, Yueting; Zhao, Huan Huan; Shen, Fenglin; Gao, Xing; Yang, Pengyuan; Liu, Xiaohui; Fu, Deliang